arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 6/2015 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    NEW ON THE MARKET

    Infliximab biosimilars INFLECTRA and REMSIMA

    Original and biosimilar: no difference?

    THERAPY FROM A CRITICAL VIEWPOINT

    IMPROVE-IT trial with ezetimibe (EZETROL, in INEGY and others)

    a-t READER'S QUESTIONS AND COMMENTS

    On the frequency of INR measurements during treatment with phenprocoumon

    Rota virus vaccination: recommendation versus actual medical care situation

    SIDE EFFECTS

    Ketoacidosis with SGLT-2 inhibitors (canagliflozin, dapagliflozin, empagliflozin)

    Agranulocytosis with febuxostat (ADENURIC)

    e a-t IN INTERNET

    Adverse drug reactions missing from product information: gliptins and bullous pemphigoid, isotretinoin and anal fissure, terbinafine and impotence
    free

    Misconduct at study sites - most often not reported in publications

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles